Life-threatening veno-occlusive disease after living-related liver transplantation [1]

Transplantation

Volumn 76, Issue 6, 2003, Pages 1007-

  Ben Ari, Ziv ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DEFIBROTIDE;

CASE REPORT; DRUG EFFICACY; HEPATITIS C; HUMAN; LETTER; LIVER TRANSPLANTATION; LIVER VENOOCCLUSIVE DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0141656216     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000082722.83766.E9     Document Type: Letter

References (6)

1. McDonald GB, Sharma P, Mathews DE, et al. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116.
2. Sterneck M, Wiesner R, Ascher N, et al. Azathioprine hepatotoxicity after liver transplantation. Hepatology 1991; 14: 806.
3. Sebagh M, Debetter M, Samuel D, et al. "Silent" presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilection. Hepatology 1999; 30: 1144.
4. Nakazawa Y, Chisuwa H, Mita A, et al. Life-threatening veno-occlusive disease after living-related liver transplantation. Transplantation 2003; 75: 727.
5. Mor E, Pappo O, Bar-Nathan N, et al. Defibrotide for the treatment of veno-occlusive disease after liver transplantation. Transplantation 2001; 72: 1237.
6. Richardson PG, Elias AD, Krishnan A, et al. Treatment of severe veno-occlusive disease with defibrotide: compassionate-use results in response without significant toxicity in a high-risk population. Blood 1998; 92: 737.